Aimei Health Technology Co Ltd (AFJKU)
Aimei Health Technology Co., Ltd. is associated with a NASDAQ-listed debt/equity composite unit, AFJK.U, rather than a standard operating share class. The issuer has no significant operating business at present and is organized around pursuing a business combination such as a merger, share exchange, asset acquisition, stock purchase, or similar reorganization. Its stated acquisition focus includes small-cap businesses in the biopharmaceutical, medical technology and device fields, as well as diagnostic and related services businesses. The company was incorporated in 2023 and is based in New York, New York.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AFJK.U
|
$12.99
|
9.1% Upside
|
Fair
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 13, 2026
|
93.0x
|
38.313 M
|
41.668 M
|
8.7%
|
45.5%
|
0.2
|
-89.9%
|
